Northwire Canada EditionSaturday, July 18, 2026
Northwire
AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0% AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0%

Healthcare

Page 111
  1. Oct 30, 2025 · 20:23 · HEM

    Hemostemix talks work in Florida

    Hemostemix talks work in Florida

    01
  2. Oct 30, 2025 · 19:00 · 4875

    MediciNova Compounds Demonstrate Novel Therapeutic Approach for Atherosclerosis in Peer-Reviewed Publication

    MediciNova Compounds Demonstrate Novel Therapeutic Approach for Atherosclerosis in Peer-Reviewed Publication

    02
  3. Oct 30, 2025 · 18:29 · PHRX

    Pharmadrug firms up deal to acquire 40% of Canurta

    Pharmadrug firms up deal to acquire 40% of Canurta

    03
  4. Oct 30, 2025 · 17:45 · GLAS

    Glass House Brands to release Q3 results Nov. 12

    Glass House Brands to release Q3 results Nov. 12

    04
  5. Oct 30, 2025 · 17:15 · GUD

    Knight Therapeutics Announces Launch of JORNAY PM(TM) in Canada

    Knight Therapeutics Announces Launch of JORNAY PM(TM) in Canada

    05
  6. Oct 30, 2025 · 16:54 · BIOV

    BIOVAXYS ANNOUNCES UPSIZING OF LIFE OFFERING OF UP TO $2M

    BIOVAXYS ANNOUNCES UPSIZING OF LIFE OFFERING OF UP TO $2M

    06
  7. Oct 30, 2025 · 16:23 · GUD

    Knight launches Minjuvi in Argentina for DLBCL patients

    Knight launches Minjuvi in Argentina for DLBCL patients

    07
  8. Oct 30, 2025 · 11:29 · HEM

    Hemostemix's Boots on the Ground in Florida October Update

    Hemostemix's Boots on the Ground in Florida October Update

    08
  9. Oct 30, 2025 · 10:45 · BNXT

    Bionxt receives EAPO readiness-to-grant notification

    Bionxt receives EAPO readiness-to-grant notification

    09
  10. Oct 30, 2025 · 09:01 · PHRX

    PharmaDrug Signs Definitive Agreement to Acquire Equity Interest in Canurta Inc

    PharmaDrug Signs Definitive Agreement to Acquire Equity Interest in Canurta Inc

    10
  11. Oct 30, 2025 · 08:00 · 4543

    OrganOx Completes Acquisition by Terumo Corporation to Advance the Future of Organ Transplantation

    OrganOx Completes Acquisition by Terumo Corporation to Advance the Future of Organ Transplantation

    11
  12. Oct 30, 2025 · 08:00 · GLAS

    Glass House Brands to Host Third Quarter 2025 Earnings Call on November 12, 2025

    Glass House Brands to Host Third Quarter 2025 Earnings Call on November 12, 2025

    12
  13. Oct 30, 2025 · 07:02 · PREV

    PreveCeutical Closes Second Tranche of Non-Brokered Private Placement

    PreveCeutical Closes Second Tranche of Non-Brokered Private Placement

    13
  14. Oct 30, 2025 · 03:05 · BNXT

    BioNxt Reports "Readiness to Grant" Patent Notification from the Eurasian Patent Organization

    BioNxt Reports "Readiness to Grant" Patent Notification from the Eurasian Patent Organization

    14
← Newer Older →